Renuka Holdings PLC (COSE:RHL.N0000)

Theseus Pharmaceuticals Balance Sheet

Financials in millions LKR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	659.09	380.62	957.89	3,234	2,298
Short-Term Investments	0.44	810.21	578.7	-	2.27
Trading Asset Securities	3,044	2,090	905.85	743.8	922.34
Cash & Short-Term Investments	3,703	3,281	2,442	3,978	3,222
Cash Growth	12.88%	34.31%	-38.60%	23.46%	75.73%
Accounts Receivable	2,826	1,812	1,702	1,427	1,066
Other Receivables	11.89	186	277.41	457.72	492.11
Receivables	2,837	1,998	1,979	1,885	1,558
Inventory	2,484	2,421	3,124	1,916	1,351
Other Current Assets	13.53	345.87	254.55	297.04	139.67
Total Current Assets	9,038	8,045	7,800	8,076	6,271
Property, Plant & Equipment	5,546	10,670	10,109	9,450	8,639
Long-Term Investments	-	-	576.17	-	169.05
Goodwill	-	242.15	180.92	180.92	157.5
Other Intangible Assets	246.96	6.36	7.99	11.54	15.26
Long-Term Deferred Tax Assets	5.31	5.76	5.69	3.68	3.35
Other Long-Term Assets	5,748	160.99	128.1	120.94	109.44
Total Assets	20,584	19,131	18,807	17,843	15,365
Accounts Payable	983	720.39	744.2	773.96	479.71
Accrued Expenses	-	1,012	813.75	449.91	299.64
Short-Term Debt	55.81	1,447	466.57	628.27	501.05
Current Portion of Long-Term Debt	4,347	1,691	1,743	1,647	1,633
Current Portion of Leases	19.43	11.3	24.69	23.11	20.74
Current Income Taxes Payable	7.9	69.17	162.47	107.89	36.06
Other Current Liabilities	0.21	9.16	30.87	233.33	104.42
Total Current Liabilities	5,413	4,960	3,985	3,864	3,074
Long-Term Debt	144.77	251.39	359.72	449.06	293.04
Long-Term Leases	167.25	142	145.34	139.1	106.99
Long-Term Deferred Tax Liabilities	950.65	931.67	965.12	715.97	681.03
Total Liabilities	6,808	6,415	5,574	5,284	4,284
Common Stock	2,368	2,368	2,295	2,223	2,223
Retained Earnings	5,676	6,059	6,196	5,745	4,807
Comprehensive Income & Other	1,011	726.03	705.7	741.44	750.12
Total Common Equity	9,055	9,154	9,197	8,709	7,780
Minority Interest	4,721	3,563	4,037	3,850	3,301
Shareholders' Equity	13,776	12,716	13,234	12,559	11,081
Total Liabilities & Equity	20,584	19,131	18,807	17,843	15,365
Total Debt	4,734	3,542	2,739	2,887	2,555
Net Cash (Debt)	-1,031	-261.74	-296.6	1,091	667.75
Net Cash Growth	-	-	-	63.45%	-
Net Cash Per Share	-5.43	-1.38	-1.56	5.77	4.99
Filing Date Shares Outstanding	189.69	189.69	189.57	189.57	189.57
Total Common Shares Outstanding	189.69	189.69	189.57	189.57	189.57
Working Capital	3,625	3,085	3,814	4,213	3,197
Book Value Per Share	47.74	48.26	48.51	45.94	41.04
Tangible Book Value	8,808	8,905	9,008	8,517	7,607
Tangible Book Value Per Share	46.43	46.95	47.52	44.93	40.13
Land	-	1,167	999.54	982.34	1,085
Buildings	-	2,170	2,153	2,128	1,836
Machinery	-	3,978	3,763	3,576	3,264
Construction In Progress	-	91.45	30.42	29.02	30.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.